> LabCorp's ($LH) soon-to-close acquisition of Covance ($CVD) will create opportunities for Quintiles ($Q), CEO Tom Pike said. More
> INC Research ($INCR) has changed things around in its C-suite, promoting COO Alistair Macdonald to president and appointing CNS President Michael Gibertini to the newly created role of president of clinical development. News
> Charles River Laboratories ($CRL) is considering reopening a long-dormant preclinical research operation in Massachusetts. Story